Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of ...

A new study reports that a routine, low-cost nutritional assessment tool may offer a powerful way to predict survival in patients with progressive pulmonary fibrosis (PPF), a life-shortening condition ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...

The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...

A metro woman was given a few years to live in 2022, after being diagnosed with a serious lung disease. However, thanks to a double lung transplant, she was given a second chance at life.

Elexacaftor-tezacaftor-ivacaftor (ETI) may improve bronchial dilatations in adolescents with cystic fibrosis (CF).

Among adults and adolescents with cystic fibrosis starting triple therapy for the first time, inflammatory markers fell and ...

Inhaled lipid nanoparticles loaded with two medicines reduced IPF lung stiffness and fibrosis in mice, outperforming an ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of the program’s price negotiations, touting a total of $12 billion ...